Dark

Check out our Dark Pool Levels

STAB
STATERA BIOPHARMA INC
stock OTC

EOD

Jul 2, 2026

0.000100USD0.000%(0.000000)899

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Dec 29, 2021

07:33AM EST Statera Biopharma Submits Phase 3 Clinical Trial Protocol To FDA For Investigational Treatment Of Pediatric Crohn's Disease Benzinga

07:32AM EST Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced submission to the U.S. Food and Drug Administration (FDA) of its Phase 3 clinical trial protocol for STAT-201 in the treatment of pediatric Crohns Disease (CD). GlobeNewswire Inc

Dec 21, 2021

09:03AM EST Statera Starts Dosing In Acute COVID-19 Trial Benzinga

Dec 20, 2021

04:04PM EST UPDATE: Statera Biopharma Sees Prelim. Data For STAT-205 Study For Acute COVID In 2022 Benzinga

04:03PM EST Statera Biopharma Reports First Patient Dosed In STAT-205 Study For Acute COVID Benzinga

04:03PM EST InitialStudy to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 GlobeNewswire Inc

Dec 1, 2021

07:40AM EST Statera Biopharma Announces FDA Lifts Clinical Hold On Entolimod In Acute Radiation Syndrome RTTNews

07:36AM EST Statera Biopharma Announces FDA Lifts Clinical Hold On Entolimod Benzinga

Nov 15, 2021

04:15PM EST Statera BioPharma Q3 EPS $(0.47) Down From $(0.06) YoY Benzinga

04:03PM EST Statera Biopharma Provides Third Quarter 2021 Financial and GlobeNewswire Inc

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

Nov 9, 2021

07:32AM EST Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company will host a conference call and live audio webcast onMonday, November 15, 2021, at 5:30 p.m. ET, to discuss its corporate and financial results for the third quarter of 2021. GlobeNewswire Inc

Nov 1, 2021

07:32AM EDT Statera Biopharma Honors Pancreatic Cancer Awareness Month GlobeNewswire Inc

Oct 19, 2021

07:40AM EDT Statera Biopharma, Inc. Announces Institutional Review Board Approves Study Of STAT-205 For Acute COVID-19 Benzinga

07:32AM EDT Researchers at Loma Linda University Health to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 GlobeNewswire Inc

Oct 15, 2021

04:15PM EDT What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders? Benzinga

Oct 6, 2021

07:33AM EDT Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company will participate in the Alliance Global Partners (A.G.P.) Biotech and Specialty Pharma Conference taking place October 13, 2021. GlobeNewswire Inc

Oct 5, 2021

07:32AM EDT Statera Biopharma Announces CEO Mike Handley to Speak During GlobeNewswire Inc

Sep 29, 2021

01:28PM EDT Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients Benzinga

Sep 23, 2021

12:33PM EDT Statera Biopharma CEO Concludes Interview On Benzinga's 'Power Hour' YouTube Show Benzinga

12:31PM EDT EXCLUSIVE: Statera Biopharma CEO Says Mgmt. Wants To Improve Pipeline In Both Depth And Breadth Benzinga

12:31PM EDT EXCLUSIVE: Statera CEO Notes Co. Is Well Capitalize, Says Will Be Opportunistic About Who We Acquiring Moving Forward Benzinga

12:24PM EDT EXCLUSIVE: Statera Biopharma CEO Begins Interview On Benzinga's 'Power Hour' YouTube Show Benzinga

11:39AM EDT EXCLUSIVE: Statera BioPharma President & Chief Executive Officer, Mike Handley To Appear On Benzinga's Power Hour Show At 12:15 p.m. EDT Benzinga

Sep 22, 2021

07:35AM EDT Statera Biopharma, Inc. to Participate in the Benzinga Healthcare Small Cap PR Newswire

Sep 21, 2021

07:31AM EDT Statera Biopharma, Inc. to Participate in the Cantor Virtual Global Healthcare PR Newswire

Sep 9, 2021

01:09PM EDT Statera BioPharma, Inc. to Ring Nasdaq Stock Market Closing Bell PR Newswire

Sep 8, 2021

07:56AM EDT What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders? Benzinga

Sep 7, 2021

08:13AM EDT Statera BioPharma: The Ticker Formerly Known as CBLI Benzinga

Sep 1, 2021

09:25AM EDT Statera BioPharma Provides Update On Integration Of ImQuest Benzinga

Share